Edwards Lifesciences Corp (EW)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Edwards Lifesciences Corp (EW) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011730
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Edwards Lifesciences Corp (Edwards) is a global medical technology company, which focuses on the development, manufacture and marketing of products and technologies used for the treatment of structural heart disease and critical conditions. It develops and commercializes heart valve products such as tissue heart valves and repair products aimed for the replacement or repair of a patient’s diseased or defective heart valve. Edwards also offers hemodynamic monitoring systems, which are used for the measurement of a patient’s cardiovascular function in the hospital setting. Edwards sells its products through direct sales force and a network of independent distributors. The company operates in North America, Europe, Asia-Pacific and other regions. Edwards is headquartered in Irvine, California, the US.

Edwards Lifesciences Corp (EW) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Edwards Lifesciences Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Edwards Lifesciences Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Edwards Lifesciences Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Edwards Lifesciences Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Edwards Lifesciences Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Edwards Lifesciences Corp, Medical Equipment, Deal Details 12
Venture Financing 12
V-Wave Raises USD28 Million in Venture Financing 12
CardioKinetix Raises USD50 Million in Venture Financing 13
Harpoon Medical Raises USD3.2 Million in Series A Financing 14
Harpoon Medical Raises USD4 Million in Venture Financing 15
Middle Peak Medical Raises US$11.5 Million In Series A Venture Financing 16
Partnerships 18
University of Maryland Enters Into Licensing Agreement With Harpoon Medical 18
EndoEvolution Enters Into Licensing Agreement With Edwards Lifesciences For Endo360 19
Edwards Lifesciences Enters Into Licensing Agreement With Harbor MedTech 20
Edwards Lifesciences Enters into Agreement with CareFusion 21
Equity Offering 22
Harpoon Medical Raises Funds through Private Placement 22
Debt Offering 23
Edwards Lifesciences Completes Public Offering Of Notes Due 2018 For US$600 Million 23
Acquisition 25
Edwards Lifesciences Acquires Harpoon Medical 25
Edwards Lifesciences Acquires Valtech Cardio 26
Edwards Lifesciences Invests in Harpoon Medical 27
Edwards Lifesciences Acquires CardiAQ for USD400 Million 28
Edwards Lifesciences Receives an Option to Acquire CardioKinetix 29
Edwards Lifesciences Acquires Bmeye, Cardiovascular Monitoring Company, For US$42 Million 30
Edwards Lifesciences Completes Acquisition Of Embrella Cardiovascular 32
Edwards Lifesciences Corp – Key Competitors 33
Edwards Lifesciences Corp – Key Employees 34
Edwards Lifesciences Corp – Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Recent Developments 38
Financial Announcements 38
Oct 24, 2017: Edwards Lifesciences Announces Third Quarter Results 38
Apr 25, 2017: Edwards Lifesciences Reports First Quarter Results 40
Feb 01, 2017: Edwards Lifesciences Reports Fourth Quarter Results 42
Oct 25, 2016: Edwards Lifesciences Reports Third Quarter Results 44
Jul 26, 2016: Edwards Lifesciences Reports Second Quarter Results 46
Feb 02, 2016: Edwards Lifesciences Reports Fourth Quarter Results 48
Corporate Communications 50
Jul 05, 2016: Leslie Heisz Appointed To Edwards Lifesciences Board Of Directors 50
Mar 17, 2016: Steven Loranger Appointed To Edwards Lifesciences Board Of Directors 51
Government and Public Interest 52
Dec 08, 2016: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference 52
Product News 54
Nov 01, 2016: Early And Sustained Quality Of Life Improvements Seen For Intermediate Risk Patients Treated With Edwards Transcatheter Valves 54
May 17, 2016: Edwards’ Surgical Heart Valve Innovations Demonstrate Positive Patient Benefits 55
03/16/2016: Edwards Lifesciences Receives Approval For SAPIEN 3 Valve In Japan 56
03/02/2016: Edwards SAPIEN XT Valve Receives FDA Approval For Pulmonic Procedures 57
Product Approvals 58
Mar 16, 2016: Edwards Lifesciences Receives Approval For SAPIEN 3 Valve In Japan 58
Mar 02, 2016: Edwards SAPIEN XT Valve Receives FDA Approval For Pulmonic Procedures 59
Appendix 60
Methodology 60
About GlobalData 60
Contact Us 60
Disclaimer 60

List of Tables
Edwards Lifesciences Corp, Medical Equipment, Key Facts, 2016 2
Edwards Lifesciences Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Edwards Lifesciences Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Edwards Lifesciences Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Edwards Lifesciences Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Edwards Lifesciences Corp, Deals By Market, 2011 to YTD 2017 9
Edwards Lifesciences Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
V-Wave Raises USD28 Million in Venture Financing 12
CardioKinetix Raises USD50 Million in Venture Financing 13
Harpoon Medical Raises USD3.2 Million in Series A Financing 14
Harpoon Medical Raises USD4 Million in Venture Financing 15
Middle Peak Medical Raises US$11.5 Million In Series A Venture Financing 16
University of Maryland Enters Into Licensing Agreement With Harpoon Medical 18
EndoEvolution Enters Into Licensing Agreement With Edwards Lifesciences For Endo360 19
Edwards Lifesciences Enters Into Licensing Agreement With Harbor MedTech 20
Edwards Lifesciences Enters into Agreement with CareFusion 21
Harpoon Medical Raises Funds through Private Placement 22
Edwards Lifesciences Completes Public Offering Of Notes Due 2018 For US$600 Million 23
Edwards Lifesciences Acquires Harpoon Medical 25
Edwards Lifesciences Acquires Valtech Cardio 26
Edwards Lifesciences Invests in Harpoon Medical 27
Edwards Lifesciences Acquires CardiAQ for USD400 Million 28
Edwards Lifesciences Receives an Option to Acquire CardioKinetix 29
Edwards Lifesciences Acquires Bmeye, Cardiovascular Monitoring Company, For US$42 Million 30
Edwards Lifesciences Completes Acquisition Of Embrella Cardiovascular 32
Edwards Lifesciences Corp, Key Competitors 33
Edwards Lifesciences Corp, Key Employees 34
Edwards Lifesciences Corp, Other Locations 35
Edwards Lifesciences Corp, Subsidiaries 35

★海外企業調査レポート[Edwards Lifesciences Corp (EW)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AltaGas Ltd.:企業の戦略・SWOT・財務情報
    AltaGas Ltd. - Strategy, SWOT and Corporate Finance Report Summary AltaGas Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Cancer Genetics Inc (CGIX):医療機器:M&Aディール及び事業提携情報
    Summary Cancer Genetics Inc (CGI) is a pharmaceutical company that provides diagnostics products and services in oncology areas. The company offers products such as CGH microarrays, next-generation sequencing and DNA-FISH Probes. Its oncology tests and laboratory services offer critical genomic info …
  • InterGen Services, Inc.:電力:M&Aディール及び事業提携情報
    Summary InterGen Services, Inc. (InterGen) is an energy utility that develops, owns, and operates power generation assets which produce energy from coal, gas and renewable sources. It is jointly owned by Ontario Teachers’ Pension Plan and China Huaneng Group/Yudean Guandong Group. The company also o …
  • Regulus Therapeutics Inc (RGLS):企業の財務・戦略的SWOT分析
    Summary Regulus Therapeutics Inc (Regulus Therapeutics) is a biopharmaceutical company that discovers and develops microRNA based therapeutics. The company provides single stranded oligonucleotides, which are chemically synthesized chains of nucleotides that are mirror images of specific target micr …
  • XCyton Diagnostics Ltd-医療機器分野:企業M&A・提携分析
    Summary XCyton Diagnostics Ltd (Xcyton) is a molecular biology company that develops and markets diagnostics products and services. The company provides ELISA kit for the detection of HIV infection; ELISA products for the detection of Neurocysticercosis, Hepatitis C and Japanese encephalitis. It pro …
  • Biafo Industries Ltd (BIFO):企業の財務・戦略的SWOT分析
    Biafo Industries Ltd (BIFO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Medison Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Medison Pharma Ltd (Medison) is marketing company which supplies and markets health care solutions to health maintenance organizations (HMO’s), medical centers, and physicians in Israel and Romania. The company offers pharmaceuticals, medical devices, and diagnostic products in the areas of …
  • Southern Co:企業の発電所・SWOT分析2018
    Southern Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execut …
  • Oval Medical Technologies Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Oval Medical Technologies Ltd (Oval Medical), a subsidiary of SMC Ltd, is a developer of patient-centric autoinjectors. The company offers cyclic olefin polymeric (COP) drug containers, which are injection moulded for customization. Based on its subcutaneous platform, the company is developi …
  • CommScope Holding Company Inc (COMM):企業の財務・戦略的SWOT分析
    CommScope Holding Company Inc (COMM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Pan American Silver Corp:企業の戦略・SWOT・財務情報
    Pan American Silver Corp - Strategy, SWOT and Corporate Finance Report Summary Pan American Silver Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Pampa Energia S.A (PAMP)-エネルギー分野:企業M&A・提携分析
    Summary Pampa Energia S.A. (Pampa) is an integrated energy company. It generates, transmits and distributes electricity. The company produces electricity from thermal, hydro and wind sources. Pampa explores for and produces hydrocarbon products in Argentina, Ecuador and Venezuela; refines diesel, fu …
  • Australian Leaders Fund Limited:企業の戦略・SWOT・財務分析
    Australian Leaders Fund Limited - Strategy, SWOT and Corporate Finance Report Summary Australian Leaders Fund Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Steel Connect Inc (STCN):企業の財務・戦略的SWOT分析
    Steel Connect Inc (STCN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Nigerian National Petroleum Corporation-石油・ガス分野:企業M&A・提携分析
    Summary Nigerian National Petroleum Corporation (NNPC) is a state-owned vertically integrated oil and gas company, which explores for, produces, markets and distributes crude oil, refined petroleum and associated by-products. It operates through a network of refineries that produce products such as …
  • Cross Timbers Royalty Trust (CRT):企業の財務・戦略的SWOT分析
    Summary Cross Timbers Royalty Trust (Cross Timbers Royalty), a subsidiary of Exxon Mobil Corp is an oil and gas company that operates oil fields. It collects and distributes monthly net profits income from overriding interests to unit holders. It also establishes cash reserves for contingencies. Cro …
  • Resona Holdings, Inc.:企業の戦略・SWOT・財務情報
    Resona Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Resona Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • China National Electronics Import & Export Corporation:戦略・SWOT・企業財務分析
    China National Electronics Import & Export Corporation - Strategy, SWOT and Corporate Finance Report Summary China National Electronics Import & Export Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company' …
  • Inter RAO UES (IRAO):企業の財務・戦略的SWOT分析
    Inter RAO UES (IRAO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • ADM Tronics Unlimited Inc (ADMT):企業の財務・戦略的SWOT分析
    ADM Tronics Unlimited Inc (ADMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆